Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glyceraldehyde-3-phosphate dehydrogenase pseudogene 54 (GAPDHP54) belongs to a large family of processed pseudogenes related to the functional GAPDH gene, a key glycolytic enzyme. Pseudogenes are noncoding genomic DNA sequences that resemble normal genes but are typically nonfunctional due to mutations or lack of regulatory elements. The human genome contains dozens of GAPDH-related pseudogenes, mostly originating via retrotransposition (copying of an mRNA back into the genome). GAPDHP54 is one such processed pseudogene and does not encode a functional enzyme nor participate in metabolic pathways or drug interactions. It is not a target for therapeutic drugs. GAPDH pseudogenes as a class can confound PCR-based assays due to sequence similarity with the functional gene. The parent gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), is a fundamental glycolytic enzyme, whereas GAPDHP54 (and its many relatives) are simply its evolutionary by-products with no known physiological function. Occasionally, pseudogenes may affect gene regulation or generate noncoding RNAs, but there is no evidence that GAPDHP54 plays such roles. Summary: GAPDHP54 is a non-functional processed pseudogene of the glycolytic enzyme GAPDH, is not a target for therapeutics or drugs, and has no direct biological, disease, or pharmacological relevance.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glyceraldehyde-3-phosphate dehydrogenase pseudogene 54 (GAPDHP54).